Cholecystitis, AcuteNCT03014817
Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial
A study testing Ultrasonically activated scalpel and Electrocautery in people with Cholecystitis, Acute, run by Karolinska Institutet at 1 site in Sweden.
Trial summary
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique offers a smoother peri- and postoperative course and reduces the risk for conversion from laparoscopic to open surgery in acute cholecystectomy patients as compared to electrocautery in case of acute cholecystitis The study… Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Cholecystitis, Acute
- What is being tested?
- Ultrasonically activated scalpel and Electrocautery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180 participants
- Where
- 1 siteSweden
- Study dates
- 1 Oct 2019to 22 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Emergency laparoscopic cholecystectomy performed for cholecystitis
- American Society of Anesthesiologists (ASA) score I-III
Who cannot join
- Patients unable to express themselves in Swedish
- Pregnancy
- Previous open surgery in the upper abdomen
- American Society of Anesthesiologists (ASA) score >III
Trial locations and contacts
1 site in 1 country.
Sweden1 site
Karolinska University Hospital, Center for Digestive Diseases
Stockholm, 14186
About this study
Official title: Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis. A Randomized, Double Blind, Multicenter Study
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique offers a smoother peri- and postoperative course and reduces the risk for conversion from laparoscopic to open surgery in acute cholecystectomy patients as compared to electrocautery in case of acute cholecystitis The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection.
Read the detailed description
Electrocautery is traditionally the method of choice for tissue dissection in laparoscopic cholecystectomy. As an alternative to electrocautery, the ultrasonically activated scalpel has proven to be an effective and safe instrument for the facilitation of dissection and to minimize blood loss in both open and laparoscopic surgery. Whereas electrocautery coagulates by burning at temperatures higher than 150ºC, the ultrasonic scalpel transforms the electric power into mechanical longitudinal vibration of the working part of the instrument by a piezoelectrical transducer. Accordingly, the former technique limits the heating- thermal necrosis effect on the tissue to the area just adjacent to the cutting line.
Since the relative-potential benefit of the ultrasonic scalpel is high in technically demanding surgery, the advantage may not be as pronounced in routine laparoscopic gallstone surgery, which can usually be done more uneventfully whichever equipment is used. Laparoscopic cholecystectomy for acute cholecystitis is, however, more demanding connected with longer operative time, more postoperative complications, greater risk of conversion to open cholecystectomy and longer postoperative stay. In addition, we know that operations for acute cholecystitis are associated with a higher risk for severe complications such as bile duct injury. The potential benefit from using the ultrasonic scalpel is thus even greater when doing surgery for cholecystitis.
In addition to this there are numerous important aspects on the safety in the implementation of the emergency cholecystectomy. Traditionally, most surgeons have chosen to operate these patients with laparoscopic technique, with the use of a so-called electrocautery hook, which usually allows tissue division with minimal blood loss. Further improvements in the dissection technique followed the introduction of ultrasonic tissue coagulation. This technique offers the option of performing these operations with even less blood loss, a more gentle handling of the inflamed tissue and a sealing of the tissue sections while the tissue is divided. Accordingly this ultrasonic tissue coagulation technique can theoretically be of significant advantage not the least when dividing acutely inflamed tissue like in acute cholecystitis with particular relevance for the dissection of the gallbladder from the liver bed, where bleeding and bile leakage often occurs. Moreover if the surgeon instead chooses to dissect the gallbladder from the doom and downwards, to the part that contains the cystic duct and cystic artery (Calots triangle), unique options can be offered to not only simplify the operation but also make it safer. This latter technique is called "fundus first".
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique combined with "fundus first" approach offers a smoother per and postoperative course in acute cholecystectomy patients as compared to the traditional way of performing the operation. Due to the lower risk of bleeding and better anatomical overview, the technique may also reduce the risk of having to convert the procedure for laparoscopic cholecystectomy to open cholecystectomy.
The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection with the "fundus first" approach.
The choice of dissection approach is determined by the randomization procedure, whether it is done from the triangle of Callot + electrocautery and upwards or from the gallbladder fundus and downwards by the use of the ultrasonic scalpel. Peroperative cholangiography is done routinely. The cystic duct is closed with a clip, not with the ultrasonic scalpel.
One month after surgery the patient is contacted by a telephone. In cases the questionnaires have not been returned yet, the patient is reminded about this. At the phone call the exact number of days of sick leave postoperatively and any adverse events occurring after discharge are recorded.
- Conditions
- Cholecystitis, Acute
- Being tested
- Ultrasonically activated scalpel, Electrocautery
- Medical subject headings
- Cholecystitis, Acute
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ultrasonically activated scalpelProcedure or surgery
Dissection with ultrasonically activated scalpel
ElectrocauteryProcedure or surgery
Dissection with electrocautery
| Study group | Role | What they receive |
|---|---|---|
| Ultrasonically activated scalpel | Experimental | Dissection with ultrasonically activated scalpel. Direction of dissection undecided but by experience most naturally fundus first. Receives: Procedure: Ultrasonically activated scalpel |
| Electrocautery | Active comparator | Dissection with electrocautery. Direction of dissection undecided but by experience most naturally cystic duct first. Receives: Procedure: Electrocautery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative complications
Postoperative complications registered according to Clavien-Dindo
Measured: 30 days
Secondary outcomes (10)
Operative time
Time required to complete surgery
Measured: 3 hours
Level of technical complexity
Level of technical complexity of the procedure as assessed by the surgeon
Measured: 3 hours
Technical performance
Perioperative technical performance assessed by an independent observer
Measured: 3 hours
Postoperative stay
Time from surgery to duscharge
Measured: 14 days
Sick leave
Time from surgery to return to work
Measured: 30 days
Conversion rate
Conversion from laparoscopic to open cholecystyectomy
Measured: 3 hours
Postoperative pain
Daily assessments of pain on a visual analogue scale
Measured: 7 days
Postoperative inflammatory activity
Daily measurements of c-reactive protein and leukocyte particle concentration
Measured: 7 days
Conversion rate
Number of procedures converted to open cholecystectomy
Measured: 3 hours
Direct and indirect medical costs
Analysis of health economics
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2017 (estimated)
- Study start1 Oct 2019
- Primary completion22 Mar 2023
- Study completion22 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cholecystitis, AcuteStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 180 participants (actual)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gabriel Sandblom, Karolinska Institutet
- Investigators
- Gabriel Sandblom, Assoc Prof, Principal investigator, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03014817
- Sponsor's protocol ID
- Ultrasonic scalpel trial
- Status last verified
- Apr 2024
- First submitted
- 5 Jan 2017
- Last updated
- 25 Apr 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Blohm M, Sandblom G, Enochsson L, Cengiz Y, Bayadsi H, Hennings J, Diaz Pannes A, Stenberg E, Bewo K, Osterberg J. Ultrasonic dissection versus electrocautery dissection in laparoscopic cholecystectomy for acute cholecystitis: a randomized controlled trial (SONOCHOL-trial). World J Emerg Surg. 2024 Nov 13;19(1):34. doi: 10.1186/s13017-024-00565-4.
PubMed 39538278
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis. A Randomized, Double Blind, Multicenter Study
- ClinicalTrials.gov ID
- NCT03014817
- Acronym / sponsor ID
- Ultrasonic scalpel trial
- Conditions
- Cholecystitis, Acute
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 180 participants (actual)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Study start
- 1 Oct 2019 (actual)
- Primary completion
- 22 Mar 2023 (actual)
- Study completion
- 22 Mar 2023 (actual)
- First posted
- 9 Jan 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique offers a smoother peri- and postoperative course and reduces the risk for conversion from laparoscopic to open surgery in acute cholecystectomy patients as compared to electrocautery in case of acute cholecystitis The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection.
Detailed description
Electrocautery is traditionally the method of choice for tissue dissection in laparoscopic cholecystectomy. As an alternative to electrocautery, the ultrasonically activated scalpel has proven to be an effective and safe instrument for the facilitation of dissection and to minimize blood loss in both open and laparoscopic surgery. Whereas electrocautery coagulates by burning at temperatures higher than 150ºC, the ultrasonic scalpel transforms the electric power into mechanical longitudinal vibration of the working part of the instrument by a piezoelectrical transducer. Accordingly, the former technique limits the heating- thermal necrosis effect on the tissue to the area just adjacent to the cutting line.
Since the relative-potential benefit of the ultrasonic scalpel is high in technically demanding surgery, the advantage may not be as pronounced in routine laparoscopic gallstone surgery, which can usually be done more uneventfully whichever equipment is used. Laparoscopic cholecystectomy for acute cholecystitis is, however, more demanding connected with longer operative time, more postoperative complications, greater risk of conversion to open cholecystectomy and longer postoperative stay. In addition, we know that operations for acute cholecystitis are associated with a higher risk for severe complications such as bile duct injury. The potential benefit from using the ultrasonic scalpel is thus even greater when doing surgery for cholecystitis.
In addition to this there are numerous important aspects on the safety in the implementation of the emergency cholecystectomy. Traditionally, most surgeons have chosen to operate these patients with laparoscopic technique, with the use of a so-called electrocautery hook, which usually allows tissue division with minimal blood loss. Further improvements in the dissection technique followed the introduction of ultrasonic tissue coagulation. This technique offers the option of performing these operations with even less blood loss, a more gentle handling of the inflamed tissue and a sealing of the tissue sections while the tissue is divided. Accordingly this ultrasonic tissue coagulation technique can theoretically be of significant advantage not the least when dividing acutely inflamed tissue like in acute cholecystitis with particular relevance for the dissection of the gallbladder from the liver bed, where bleeding and bile leakage often occurs. Moreover if the surgeon instead chooses to dissect the gallbladder from the doom and downwards, to the part that contains the cystic duct and cystic artery (Calots triangle), unique options can be offered to not only simplify the operation but also make it safer. This latter technique is called "fundus first".
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique combined with "fundus first" approach offers a smoother per and postoperative course in acute cholecystectomy patients as compared to the traditional way of performing the operation. Due to the lower risk of bleeding and better anatomical overview, the technique may also reduce the risk of having to convert the procedure for laparoscopic cholecystectomy to open cholecystectomy.
The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection with the "fundus first" approach.
The choice of dissection approach is determined by the randomization procedure, whether it is done from the triangle of Callot + electrocautery and upwards or from the gallbladder fundus and downwards by the use of the ultrasonic scalpel. Peroperative cholangiography is done routinely. The cystic duct is closed with a clip, not with the ultrasonic scalpel.
One month after surgery the patient is contacted by a telephone. In cases the questionnaires have not been returned yet, the patient is reminded about this. At the phone call the exact number of days of sick leave postoperatively and any adverse events occurring after discharge are recorded.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ultrasonically activated scalpel | Experimental | Procedure: Ultrasonically activated scalpelDissection with ultrasonically activated scalpel. Direction of dissection undecided but by experience most naturally fundus first. |
| Electrocautery | Active comparator | Procedure: ElectrocauteryDissection with electrocautery. Direction of dissection undecided but by experience most naturally cystic duct first. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Emergency laparoscopic cholecystectomy performed for cholecystitis
- American Society of Anesthesiologists (ASA) score I-III
Key exclusion criteria (4 listed)
- Patients unable to express themselves in Swedish
- Pregnancy
- Previous open surgery in the upper abdomen
- American Society of Anesthesiologists (ASA) score >III
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ultrasonically activated scalpelDissection with ultrasonically activated scalpel | Procedure or surgery | Ultrasonically activated scalpel |
| ElectrocauteryDissection with electrocautery | Procedure or surgery | Electrocautery |
Primary outcome
Postoperative complications
Time frame: 30 days
Postoperative complications registered according to Clavien-Dindo
10 secondary outcomes
Operative time
Time frame: 3 hours
Level of technical complexity
Time frame: 3 hours
Technical performance
Time frame: 3 hours
Postoperative stay
Time frame: 14 days
Sick leave
Time frame: 30 days
Conversion rate
Time frame: 3 hours
Postoperative pain
Time frame: 7 days
Postoperative inflammatory activity
Time frame: 7 days
Conversion rate
Time frame: 3 hours
Direct and indirect medical costs
Time frame: 30 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2024.
- Derived from this study: PubMed 39538278Blohm M, Sandblom G, Enochsson L, Cengiz Y, Bayadsi H, Hennings J, Diaz Pannes A, Stenberg E, Bewo K, Osterberg J. Ultrasonic dissection versus electrocautery dissection in laparoscopic cholecystectomy for acute cholecystitis: a randomized controlled trial (SONOCHOL-trial). World J Emerg Surg. 2024 Nov 13;19(1):34. doi: 10.1186/s13017-024-00565-4.
- Individual participant dataSharing planned: No
Related trials for Cholecystitis, Acute
Not yet recruitingObservational study
SnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis
Cholecystitis, Acute
Not yet recruiting
Percutaneous Drainage Versus EUS-guided Gallbladder Drainage in Poor Surgical Patients With Cholecystitis
Cholecystitis, Acute
RecruitingObservational study
Influence of Gut Microbiome in Gallstone Disease
Gall Stone, Gall Stones, Common Bile Duct
Recruiting
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
Cholecystitis, Acute, Biliary Diseases
Recruiting
Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage
Acute Cholecystitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gabriel Sandblom, Assoc Prof principal investigator
Karolinska Institutet
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ultrasonically activated scalpel and Electrocautery in people with Cholecystitis, Acute, run by Karolinska Institutet at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative complications (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03014817, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2024.